Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Endocr J
; 70(5): 489-500, 2023 May 29.
Article
in En
| MEDLINE
| ID: mdl-36792218
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hyperaldosteronism
/
Hypertension
/
Hypokalemia
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Endocr J
Journal subject:
ENDOCRINOLOGIA
Year:
2023
Type:
Article
Affiliation country:
Japan